PLSE

Pulse Biosciences Inc.

Price

$49.12

return (12m)

154.61%

p/e

-42.45

p/bv

34.16

DIVIDEND YIELD

0.00%

PLSE price

Pulse Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PLSE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-8.47%

3 months

65.65%

1 year

154.61%

2 years

205.06%

5 years

141.59%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PLSE

Valuation

P/E

-42.45

Sector 1.27

Industry 8.57

P/BV

34.16

Sector 1.88

Industry 3.63

P/Revenue (PSR)

2,868.15

Sector 1.56

Industry 3.09

EV/EBITDA

-131.79

Sector -46.85

Industry -17.98

EV/EBIT

-130.47

Sector -51.35

Industry -94.21

P/EBITDA

-41.44

Sector -31.66

Industry 7.07

P/EBIT

-40.93

Sector -43.19

Industry -32.11

P/Total Assets

29.41

Sector 0.87

Industry 1.32

P/Net Current Assets

37.92

Sector -26.04

Industry -3.44

P/Working Capital

35.88

Sector -4.00

Industry 7.65

EPS

-1.16

Sector -0.70

Industry -0.23

BVPS

1.44

Sector 4.48

Industry 8.61

Efficiency

Gross Margin

22.19%

Sector 49.44%

Industry 55.16%

EBITDA Margin

-5,764.52%

Sector -282.02%

Industry -13.47%

EBIT Margin

-5,823.04%

Sector -164.03%

Industry -25.89%

Operating Margin

-100.00%

Sector -19.60%

Industry -5.67%

Net Profit Margins

-100.00%

Sector -23.82%

Industry -7.67%

Asset Turnover

0.00

Sector 0.13

Industry 0.13

Profitability

ROE

-80.46%

Sector -23.80%

Industry -24.00%

ROA

-69.27%

Sector -24.22%

Industry -5.96%

ROIC

-655.22%

Sector -587.47%

Industry -21.90%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

9.63

Sector 1.90

Industry 2.56

Net Debt / EBITDA

4.06

Sector -23.34

Industry 9.41

Net Debt / EBIT

4.02

Sector -11.26

Industry -2.82

Net Debt / Equity

-1.02

Sector -0.63

Industry -0.19

Gross Debt / Equity

0.00

Sector -0.73

Industry 0.42

Equity/Assets

0.86

Sector 0.46

Industry 0.50

Liabilities/Assets

0.14

Sector 0.50

Industry 0.53

Growth

5Y Revenue CAGR

15.60%

Sector -

Industry -

5Y Earnings CAGR

4.69%

Sector -

Industry -

Fundamentals PLSE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PLSE Pulse Biosciences Inc.	$49.12	171.05%	0.00%	-42.45	34.16	-80.46%	-100.00%
ABT Abbott Laboratories	$96.56	-25.26%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$86.94	-4.56%	3.30%	21.10	2.17	10.29%	13.93%
BSX Boston Scientific Corp.	$42.80	-55.35%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$77.58	-32.47%	0.00%	17.68	5.18	29.28%	22.69%
RMD ResMed Inc.	$220.18	-17.85%	1.12%	20.92	4.84	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$520.16	-16.12%	0.00%	36.04	25.47	70.67%	25.03%
COHR Coherent Inc.	$336.58	193.57%	0.00%	81.57	5.84	7.16%	11.31%
SYK Stryker Corp.	$275.16	-23.42%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$23.86	-10.29%	4.25%	17.60	1.72	9.80%	6.30%
INMD InMode Ltd.	$14.05	-8.08%	0.00%	10.69	1.32	12.32%	20.69%
BDX Becton Dickinson and Company	$176.01	-5.53%	2.39%	51.40	1.98	3.85%	6.29%
DXCM DexCom Inc.	$85.41	29.25%	0.00%	32.65	12.45	38.14%	20.12%
EW Edwards Lifesciences Corp.	$85.35	11.85%	0.00%	48.96	4.59	9.37%	15.43%
ALGN Align Technology Inc.	$145.01	13.72%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$26.32	-25.97%	2.96%	19.66	4.27	21.74%	9.20%
IRMD iRadimed Corporation	$85.25	22.44%	1.49%	47.27	10.71	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$87.75	-10.09%	1.10%	20.85	1.33	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PLSE - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Pulse Biosciences

Pulse Biosciences Inc.

Average Investor10 user rating

4.0 (0 people)

United States

12 years

Founded: 2014

2016

Time since IPO - 10 years

95

Employees

Pulse Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $3.40 billion, with shareholders equity totaling $99.50 million.

The company employs approximately 95 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Pulse Biosciences Inc. reported $1.19 million in revenue, generating net income of $-80.06 million.

Key financial metrics include a P/E ratio of -42.45, a price-to-book (P/B) ratio of 34.16, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PLSE.

Market cap

$3.40 billion

Net worth

$99.50 million

$99,500,000.00

Assets

$115.56 million

$115,564,000.00

Total Shares Outstanding

69.20 million

69,200,000

Average Daily Trading Volume

$551.60 Thousand

$551,603.26

Sector

Health

Industry

Medical Supplies and Equipment

PLSE

PLSE revenue and profits

Financial Results PLSE

DRAG THE FRAME TO SEE MORE DATA

PLSE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$86.67 15,38% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$267.68 --11,99% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$62.50 61,49% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$383.17 37,00% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$39.70 --18,93% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$255.81 38,68% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,139.27 36,51% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$428.58 0,25% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45